Character | Response | |
---|---|---|
|
|
|
|
|
|
|
|
|
|
|
|
Character | Response | |
---|---|---|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Class | Active | Resistant |
---|---|---|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
N/A
Gardnerella vaginalis is one of several vaginal organisms whose presence strongly correlates with BV. Biochemical and physiological analyses demonstrate important virulence features such as hemolytic activity, epithelial adhesion and biofilm formation. Genomic analyses provides details of the genetic elements involved. We also identify other features of the G. vaginalis pangenome, such as the ability to degrade mucin, evade immune detection or resist a broad spectrum of antimicrobials, which may be important to the role of G. vaginalis in BV. [PMID: 20865041]
Gardnerella vaginalis (strain 409-05) is a facultative anaerobic Gram-variable bacterium. It is the most prevalent sexually transmitted organism and is associated with bacterial vaginosis (BV) in which the normal lactobacilli microbiota is replaced by relatively high concentrations of other bacteria, especially G. vaginalis. It reflects a complex alteration of the vaginal microbiota, normally in the absence of inflammatory response. It generally leads to the presence of intense discharges in the absence of itching, burning sensations or urinary symptoms. G. vaginalis was found to be a risk factor for the acquisition of human immunodeficiency virus (HIV), in which stimulation of HIV expression by G. vaginalis was demonstrated. This bacterium is also associated with bacteraemia, urinary track infections, and neonatal meningitis. (Adaptated from PMID: 20221621). [UP000001888]
Lineage | Physiology | General | Growth Tolerances | Hydrol./digest./degr. |
|
|
Health: Unknown
Source: human faeces, clinical sources (UTI, blood) and vagina
DNA G+C(%): 41.0-42.8
|
Opt. T: 35℃
Lower T(℃): 25(+)
High T(℃): 42(+)
Opt. pH: 6.0-6.5
pH 4.2-5.9: 4.5(w)
|
|
---|
Monosaccharide O/F | Oligosaccharide O/F | Polysaccharide O/F | Polyol O/F | Other O/F |
|
|
|
|
|
---|
Enzymes: General | Enzymes: Carbohydrate | Enzymes: Protein | Enzymes: Arylamidases | Enzymes: Esters/fats |
|
|
|
|
|
---|
Fuel | Usable Metabolites | Metabolites Released | Special Products | Compounds Produced |
|
---|
Penicillins & Penems (μg/mL) | Cephalosporins (μg/mL) | Aminoglycosides (μg/mL) | Macrolides (μg/mL) | Quinolones (μg/mL) |
penicillin: Res
penicillin_G: SensRNG: (0.25/-)
|
cefoxitin: Var(MIC50): 0.5, MIC90: 4, RNG: (0.06->16)
|
streptomycin: Res
|
|
garenoxacin: S(MIC50): 0.5, MIC90: 1, RNG: (0.015-8)
levofloxacin: S(MIC50): 1, MIC90: 1, RNG: (0.5-8)
|
---|---|---|---|---|
Tetracyclines (μg/mL) | Vancomycin Class (μg/mL) | Polypep/ketides (μg/mL) | Heterocycles (μg/mL) | Other (μg/mL) |
doxycycline: Var(MIC50): 1, MIC90: 16, RNG: (0.125-32)
chlortetracycline: Sens
oxytetracycline: Sens
tetracycline: Sens
|
|
bacitracin: Sens
|
chloramphenicol: R(vr)
metronidazole: R(MIC50): >8, MIC90: >32, RNG: (<0.25->32)
|
clindamycin: S(MIC50): 0.03, MIC90: 0.125, RNG: (0.03-0.25)
polymyxin_B: Res
|